Search form

Search form

U.S. Reps. Joe Barton, R-Texas, and John Shimkus, R-Ill., are asking the Government Accountability Office to investigate delays by the FDA in disciplining researchers who violated patient-safety rules during clinical trials. FDA officials say they are working on improving the disciplinary process.

Related Summaries

U.S. Reps. Joe Barton, R-Texas, and John Shimkus, R-Ill., are asking the Government Accountability Office to investigate the FDA's oversight of clinical drug trials. The letter cited a Bloomberg News story about the FDA's failure to fully carry out disciplinary measures against 12 researchers who breached rules on patient safety and accuracy of trial data. FDA officials say they are working on improving the disciplinary process.

U.S. Reps. Joe Barton, R-Texas, and John Shimkus, R-Ill., are asking the Government Accountability Office to investigate how the FDA reviews clinical drug trials. The letter cited a Bloomberg News story about the FDA's failure to fully carry out disciplinary measures against 12 researchers who breached rules on patient safety and accuracy of trial data. FDA officials say they are working on improving the disciplinary process.

U.S. Reps. Joe Barton, R-Texas, and John Shimkus, R-Ill., are asking the Government Accountability Office to investigate how the FDA reviews clinical drug trials. The letter cited a Bloomberg News story about the FDA's failure to fully carry out disciplinary measures against 12 researchers who breached rules on patient safety and accuracy of trial data. FDA officials say they are working on improving the disciplinary process.

Patients harmed in clinical drug trials often lack a clear route to compensation. Federal law does not require researchers to pay injured trial participants. Attorneys say informed-consent forms make litigation difficult, and it can be hard to establish what damage was caused by the trial as opposed to the patient's disease.

Patients harmed in clinical drug trials often lack a clear route to compensation. Federal law does not require researchers to pay injured trial participants. Attorneys say informed-consent forms make litigation difficult, and it can be hard to establish what damage was caused by the trial as opposed to the patient's disease.